Haverford Trust Co Cuts Position in Aflac Incorporated (NYSE:AFL)

Haverford Trust Co lowered its stake in shares of Aflac Incorporated (NYSE:AFL) by 1.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 7,509 shares of the financial services provider’s stock after selling 109 shares during the period. Haverford Trust Co’s holdings in Aflac were worth $777,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Private Trust Co. NA grew its holdings in shares of Aflac by 1.3% in the 4th quarter. Private Trust Co. NA now owns 7,643 shares of the financial services provider’s stock worth $791,000 after acquiring an additional 99 shares during the period. Phillips Wealth Planners LLC boosted its position in Aflac by 1.5% during the fourth quarter. Phillips Wealth Planners LLC now owns 6,553 shares of the financial services provider’s stock worth $662,000 after purchasing an additional 100 shares in the last quarter. Raleigh Capital Management Inc. grew its holdings in Aflac by 23.2% in the fourth quarter. Raleigh Capital Management Inc. now owns 531 shares of the financial services provider’s stock valued at $55,000 after purchasing an additional 100 shares during the last quarter. TKG Advisors LLC increased its position in shares of Aflac by 0.5% in the fourth quarter. TKG Advisors LLC now owns 21,255 shares of the financial services provider’s stock valued at $2,230,000 after buying an additional 103 shares in the last quarter. Finally, Robertson Stephens Wealth Management LLC raised its stake in shares of Aflac by 1.6% during the 4th quarter. Robertson Stephens Wealth Management LLC now owns 6,960 shares of the financial services provider’s stock worth $720,000 after buying an additional 107 shares during the last quarter. 67.44% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on AFL shares. BMO Capital Markets assumed coverage on shares of Aflac in a research note on Thursday, January 23rd. They issued a “market perform” rating and a $111.00 price objective on the stock. Morgan Stanley increased their price target on shares of Aflac from $98.00 to $105.00 and gave the company an “equal weight” rating in a research report on Friday, February 28th. Piper Sandler cut their price objective on Aflac from $122.00 to $118.00 and set an “overweight” rating for the company in a research report on Friday, February 7th. Wells Fargo & Company lowered their target price on Aflac from $104.00 to $102.00 and set an “equal weight” rating on the stock in a report on Wednesday, February 19th. Finally, JPMorgan Chase & Co. lifted their price target on shares of Aflac from $90.00 to $94.00 and gave the stock a “neutral” rating in a report on Tuesday, January 7th. Two equities research analysts have rated the stock with a sell rating, eleven have given a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, Aflac currently has a consensus rating of “Hold” and an average price target of $103.36.

Aflac Price Performance

AFL stock opened at $109.70 on Tuesday. The company has a market cap of $59.96 billion, a PE ratio of 11.43, a price-to-earnings-growth ratio of 3.24 and a beta of 0.93. Aflac Incorporated has a 12-month low of $79.31 and a 12-month high of $115.50. The company has a current ratio of 0.10, a quick ratio of 0.08 and a debt-to-equity ratio of 0.29. The stock has a 50-day moving average price of $106.09 and a two-hundred day moving average price of $107.61.

Aflac (NYSE:AFL) last issued its earnings results on Wednesday, February 5th. The financial services provider reported $1.56 EPS for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. As a group, research analysts predict that Aflac Incorporated will post 6.88 EPS for the current year.

Insider Transactions at Aflac

In other Aflac news, EVP Audrey B. Tillman sold 24,744 shares of the stock in a transaction that occurred on Friday, December 27th. The shares were sold at an average price of $103.40, for a total value of $2,558,529.60. Following the completion of the sale, the executive vice president now owns 222,618 shares of the company’s stock, valued at $23,018,701.20. This trade represents a 10.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Joseph L. Moskowitz sold 1,000 shares of the business’s stock in a transaction on Friday, March 7th. The stock was sold at an average price of $107.63, for a total transaction of $107,630.00. Following the transaction, the director now directly owns 25,393 shares in the company, valued at approximately $2,733,048.59. The trade was a 3.79 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 55,546 shares of company stock valued at $5,863,616 over the last quarter. Company insiders own 0.90% of the company’s stock.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.